Epigenetic markers of prostate cancer in plasma circulating DNA-Reference-Cited by-同舟云学术

Epigenetic markers of prostate cancer in plasma circulating DNA

Published:2012-05-22 Issue:16 Volume:21 Page:3619-3631
ISSN:0964-6906
Container-title:Human Molecular Genetics
language:en
Short-container-title:

Author:

Cortese Rene,Kwan Andrew,Lalonde Emilie,Bryzgunova Olga,Bondar Anna,Wu Ying,Gordevicius Juozas,Park Mina,Oh Gabriel,Kaminsky Zachary,Tverkuviene Justina,Laurinavicius Arvydas,Jankevicius Feliksas,Sendorek Dorota H.S.,Haider Syed,Wang Sun-Chong,Jarmalaite Sonata,Laktionov Pavel,Boutros Paul C.,Petronis Arturas

Publisher

Oxford University Press (OUP)

Subject

Genetics(clinical),Genetics,Molecular Biology,General Medicine

Reference81 articles.

1. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?;Lung Cancer,2005

2. American Cancer Society guideline for the early detection of prostate cancer: update 2010;CA Cancer J. Clin.,2010

3. Cancer statistics, 2010;CA Cancer J. Clin.,2010

4. Screening for prostate cancer—the controversy that refuses to die;N. Engl. J. Med.,2009

5. Mortality results from a randomized prostate-cancer screening trial;N. Engl. J. Med.,2009

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TIAM1 signaling drives prostatic budding and branching phenotypes and is a potential therapeutic target for BPH;2024-02-05

2. Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection;Cancers;2023-01-29

3. Locus-Specific Bisulfate NGS Sequencing of GSTP1, RNF219, and KIAA1539 Genes in the Total Pool of Cell-Free and Cell-Surface-Bound DNA in Prostate Cancer: A Novel Approach for Prostate Cancer Diagnostics;Cancers;2023-01-09

4. Artificial Intelligence for Clinical Diagnosis and Treatment of Prostate Cancer;Cancers;2022-11-14

5. Diagnostic role of plasma ORM2 in differentiating prostate cancer from benign prostatic hyperplasia;Journal of Cancer Research and Clinical Oncology;2022-10-05